Financial Architects (New Jersey)’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Financial Architects (New Jersey)’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-36	Closed	-$1K	–	1649
2017 Q4	$1K	Sell	36 -108	-75%	-$1.46K	﹤0.01%	1462
2017 Q3	$3K	Hold	144	–	–	﹤0.01%	1391
2017 Q2	$2K	Buy	144 +12	+9%	+$183	﹤0.01%	1453
2017 Q1	$2K	Hold	132	–	–	﹤0.01%	1481
2016 Q4	$2K	Hold	132	–	–	﹤0.01%	1317
2016 Q3	$2K	Hold	132	–	–	﹤0.01%	1372
2016 Q2	$1K	Buy	132 +26	+25%	+$268	﹤0.01%	1415
2016 Q1	$1K	Buy	+106	New	+$1.14K	﹤0.01%	1152
2015 Q3	–	Sell	-70	Closed	-$2K	–	1041
2015 Q2	$2K	Buy	+70	New	+$1.39K	﹤0.01%	1130

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Financial Architects (New Jersey)'s MNTA Position: Q1 2018 in Review

Financial Architects (New Jersey) sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2018, closing a stake of 36 shares — an estimated $1K sold.

Financial Architects (New Jersey) first reported a position in MNTA in Q2 2015 and held it in 9 quarters. The position peaked at $3K in Q3 2017. 163 funds tracked by Wall St. Rank hold MNTA as of Q1 2018.

Financial Architects (New Jersey) reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Financial Architects (New Jersey) sold 36 Momenta Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1K.
Financial Architects (New Jersey) first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2015 and held it in 9 quarters.
Financial Architects (New Jersey)'s Momenta Pharmaceuticals, Inc. position peaked at $3K in Q3 2017.
163 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2018.

Based on Financial Architects (New Jersey)'s 13F filing for Q1 2018, filed 23 Apr 2018.